Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Which Crypto Should Newbies Buy First guides you to practical, beginner-friendly first purchases.
27,491 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Electrocore (ECOR) is navigating a pivotal year. This article dives into the 2025 earnings landscape, unpacking reven...
This year brought a sharp retreat in Accenture’s stock. The drop isn’t just a price move—it's a signal. This guide br...
In early 2026, retirees are increasingly adopting a low-volatility ETF to stabilize portfolios amid ongoing market vo...
Investors eye Omada Health as it reports Q1 2026 results. This analysis breaks down the earnings narrative, key metri...
A large insider sale at Relay Therapeutics coincides with a dramatic stock rally. This article breaks down what the r...
As Elanco maps out its path for 2025, investors weigh growth drivers, margins, and catalysts. This guide breaks down ...
Insider moves can shed light on a company’s trajectory, but they aren’t a crystal ball. This guide breaks down biotec...
In 2026, one AI-focused stock has become the darling of bulls and analysts alike. This article dives into the reasons...
Investor-focused guide to perimeter solutions earnings. Learn how revenue, margins, and cash flow shape PRM stock pro...
This deep-dive breaks down veru (veru) 2026 earnings, translating the quarterly numbers into a clear sense of cash he...
When a chief financial officer sells a large block of stock, investors sit up and take notice. This article breaks do...